82614 Federal Register / Vol. 89, No. 198 / Friday, October 11, 2024 / Notices 

Fulfillment of these commitments 

will be reflected through the issuance of 

updated guidance on existing topics, 

withdrawal of guidances that no longer 

reflect FDA’s current thinking on a 

particular topic, and annual updates to 

the A-list and B-list announced in this 

notice. 

II. Website Location of Guidance Lists 

This notice announces the website 

location of the document that provides 

the A- and B-lists of guidance 

documents, which CDRH is intending to 

publish during FY 2025. To access these 

two lists, visit FDA’s website at https:/ 

www.fda.gov/medical-devices/guidancedocuments-medical-devices-andradiation-emitting-products/cdrhproposed-guidance-development. We 

note that the topics on these lists may 

be removed or modified based on 

current priorities, as well as comments 

received regarding these lists. 

Furthermore, FDA and CDRH priorities 

are subject to change at any time (e.g., 

newly identified safety issues). The 

Agency is not required to publish every 

guidance on either list if the resources 

needed would be to the detriment of 

meeting quantitative review timelines 

and statutory obligations. In addition, 

the Agency is not precluded from 

issuing guidance documents that are not 

on either list. 

Dated: October 7, 2024. 

Eric Flamm, 

Acting Associate Commissioner for Policy. 

[FR Doc. 2024–23544 Filed 10–10–24; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Advisory Committee on 

Minority Health 

AGENCY: Office of Minority Health, 

Office of the Secretary, U.S. Department 

of Health and Human Services. 

ACTION: Notice of meeting. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the U.S. 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that the Advisory Committee on 

Minority Health (ACMH) will hold a 

meeting. This meeting will be open to 

the public. Preregistration is required 

for the public to attend the meeting, 

provide comments, and/or distribute 

printed material(s) to ACMH members. 

Information about the meeting is 

available from the designated contact 

person and will be posted on the HHS 

Office of Minority Health (OMH) 

website: www.minorityhealth.hhs.gov. 

Information about ACMH activities can 

be found on the OMH website under the 

heading About OMH, Committees and 

Working Groups. 

DATES: The ACMH meeting will be held 

on November 14–15, 2024 from 8:30 

a.m. to 5:30 p.m. EST each day. If the 

Committee completes its work before 

5:30 p.m., the meeting will adjourn 

early. 

ADDRESSES: The meeting will be held at 

the Tower Building at 1101 Wootton 

Parkway, Lower-Level Conference 

Room, Rockville, Maryland 20852 and 

will be accessible by webcast. Members 

of the public must register for the 

meeting by 5:00 p.m. EST on October 

29, 2024. Registered webcast 

participants will receive webcast access 

information prior to the meeting. 

FOR FURTHER INFORMATION CONTACT: 

Violet Woo, Designated Federal Officer, 

Advisory Committee on Minority 

Health, OMH, HHS, Tower Building, 

1101 Wootton Parkway, Suite 100, 

Rockville, Maryland 20852. Phone: 240– 

453–6816; email: OMH-ACMH@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Establishment of the ACMH is 

mandated under section 1707(c) of the 

PHS Act (42 U.S.C 300u–6(c) to provide 

advice to the Deputy Assistant Secretary 

for Minority Health on the development 

of goals and program activities related to 

OMH’s duties. 

The topic to be discussed during the 

meeting is the implementation of the 

updated Office of Management and 

Budget (OMB) federal race and ethnicity 

data collection standards. The focus will 

be opportunities for engagement with 

racial, ethnic, and tribal communitylevel organizations to support increased 

awareness of the race and ethnicity data 

collection standards and their intended 

goals within their communities. The 

recommendations will be given to the 

Deputy Assistant Secretary for Minority 

Health to inform efforts related to 

implementation of the revised OMB 

standards. Information on OMB’s 

updated federal race and ethnicity data 

collection standards can be found on 

this website: spd15revision.gov. 

The meeting is open to the public. 

Any individual who wishes to attend 

the meeting must register by sending an 

email to OMH-ACMH@hhs.gov by 5:00 

p.m. EST on October 29, 2024. Each 

registrant should provide their name, 

affiliation, email address, days 

attending, if planning to provide public 

verbal comments or printed statement, 

and if participation is in-person or via 

webcast. Registrants will receive 

webcast access information via email. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

contact OMH-ACMH@hhs.gov and 

reference this meeting. Requests for 

special accommodation should be made 

during registration or at least ten (10) 

business days prior to the meeting. 

Registered members of the public will 

have an opportunity to provide 

comments at the meeting. Public 

comments will be limited to two 

minutes per registered speaker during 

the time allotted. Individuals of the 

public may also submit and distribute 

electronic or printed statements or 

material(s) related to this meeting’s 

topic. Written statements or material(s) 

should be double-spaced with one-inch 

margins and not exceed two pages in 

length. Any content beyond the twopage limit will not be presented to the 

Committee. Individuals planning to 

submit electronic or printed material 

should email the material to OMHACMH@hhs.gov at least ten (10) 

business days prior to the meeting. 

Violet Woo, 

Designated Federal Officer, Advisory 

Committee on Minority Health. 

[FR Doc. 2024–23582 Filed 10–10–24; 8:45 am] 

BILLING CODE 4150–29–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group; Neural Basis of Psychopathology, 

Addictions and Sleep Disorders Study 

Section. 

Date: November 7–8, 2024. 

Time: 8:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: Hyatt Place Georgetown, 2121 M 

Street, Washington, DC 20037. 

Meeting Format: In Person. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 198 / Friday, October 11, 2024 / Notices 82615 

Contact Person: Todd Everett White, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 594–3962, todd.white@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Medical Imaging. 

Date: November 7–8, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Krystyna H. Szymczyk, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 480–4198, szymczykk@

csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Cancer Diagnosis and Treatments 

(CDT). 

Date: November 7–8, 2024. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Victor A. Panchenko, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 802B2, 

Bethesda, MD 20892, (301) 867–5309, 

victor.panchenko@nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; Genetic 

Variation and Evolution Study Section. 

Date: November 7–8, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: The Bethesdan Hotel, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Meeting Format: In Person. 

Contact Person: Michael Patrick O’Connell, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 867–5309, oconnellmp@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Cell Biology, Developmental 

Biology, and Bioengineering. 

Date: November 7, 2024. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Mark Caprara, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5156, 

MSC 7844, Bethesda, MD 20892, 301–613– 

5228, capraramg@mail.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group; Neurobiology of 

Motivated Behavior Study Section. 

Date: November 7–8, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Janita N. Turchi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 402–4005, turchij@mail.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Neural Oxidative Metabolism 

and Death Study Section. 

Date: November 7–8, 2024. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Christine Jean DiDonato, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1014J, 

Bethesda, MD 20892, (301) 435–1042, 

didonatocj@csr.nih.gov. 

Name of Committee: Aging and 

Neurodegeneration Integrated Review Group; 

Cellular and Molecular Biology of 

Neurodegeneration Study Section. 

Date: November 7–8, 2024. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: In Person and Virtual 

Meeting. 

Contact Person: Laurent Taupenot, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4188, 

MSC 7850, Bethesda, MD 20892, 301–435– 

1203, laurent.taupenot@nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology A Integrated Review Group; 

Innate Immunity B Study Section. 

Date: November 7–8, 2024. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: In Person and Virtual 

Meeting. 

Contact Person: Bakary Drammeh, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 805–P, 

Bethesda, MD 20892, (301) 435–0000, 

drammehbs@csr.nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

Aging, Injury, Musculoskeletal, and 

Rheumatologic Disorders Study Section. 

Date: November 7–8, 2024. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Nketi I. Forbang, MD, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1006K1, 

Bethesda, MD 20892, (301) 594–0357, 

forbangni@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 7, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–23542 Filed 10–10–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel; NIAMS 

Ancillary 2025/01 Review Meeting. 

Date: November 12, 2024. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Chiguang Feng, Ph.D., 

Scientific Review Officer, Scientific Review 

Officer, Scientific Review Branch, Extramural 

Program, Arthritis and Musculoskeletal and 

Skin Diseases, 6701 Democracy Boulevard, 

Bethesda, MD 30892, (301) 451–7766, 

chiguang.feng@nih.gov. 


ddrumheller on DSK120RN23PROD with NOTICES1